GM Helix Acqua Implant, Article Number: 140.985

FDA Device Recall #Z-1863-2025 — Class II — May 1, 2025

Recall Summary

Recall Number Z-1863-2025
Classification Class II — Moderate risk
Date Initiated May 1, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Straumann USA LLC
Location Andover, MA
Product Type Devices
Quantity 207 units (54 US, 153 OUS)

Product Description

GM Helix Acqua Implant, Article Number: 140.985

Reason for Recall

It is possible that a package labelled as an 11.5 mm implant may contain a 13 mm implant instead.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of AZ, CA, CO, FL, GA, Il KS, LA, MA, MD, MI, NE, NH, NJ, NY, OH, OK, RI, SC, TN, TX, UT, WI and the countries of Australia, Croatia, France, Hungary, India, Italy, Lebanon, Lithuania, New Zealand, Portugal, Qatar, Serbia, Spain, Tunisia, UAE, United Kingdom, Vietnam.

Lot / Code Information

Article Number: 140.985; UDI-DI: (01)7899878024569(11)220125(17)270124(10)JPZ75; Lot number: JPZ75;

Other Recalls from Straumann USA LLC

Recall # Classification Product Date
Z-1633-2026 Class II Custom Abutment AS Ti, for Straumann RC, incl. ... Mar 17, 2026
Z-1632-2026 Class II Custom Abutment Ti, for Straumann RC, incl. TAN... Mar 17, 2026
Z-1337-2026 Class III WB Impression Post Closed Tray incl. guide scre... Jan 6, 2026
Z-0582-2026 Class II Emdogain; Article Numbers: (1) 440.230V10, (2)... Oct 17, 2025
Z-1862-2025 Class II GM Helix Acqua Implant, Article Number: 140.984 May 1, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.